WASHINGTON (AP) -- The Food and Drug Administration says Merck's cholesterol drug Vytorin helps reduce heart attack, stroke and related problems in patients with kidney disease, a potential new use for the blockbuster drug....
cholesterol drugFDA backs Vytorin for kidney disease patientsHeadlines from the Associated Press Mon, 10/31/2011 - 09:41
FDA backs Vytorin for kidney disease patientsSeattle Post-Intelligencer: Health and Fitness Mon, 10/31/2011 - 08:25
Share: Tags:
Report says Pfizer may try to market OTC LipitorHeadlines from the Associated Press Wed, 08/03/2011 - 15:03
NEW YORK (AP) -- Pfizer Inc. on Wednesday declined to comment on reports it hopes to start marketing an over-the-counter version of its cholesterol drug Lipitor, the world's biggest-selling prescription drug, after the original version loses patent protection in November.... Report says Pfizer may try to market OTC LipitorSeattle Post-Intelligencer: Health and Fitness Wed, 08/03/2011 - 15:03
Share: Study: Cholesterol drug lowers blood clot riskHeadlines from the Associated Press Sun, 03/29/2009 - 10:59
ORLANDO, Fla. (AP) -- Statin drugs, taken by millions of Americans to lower cholesterol and prevent heart disease, also can cut the risk of developing dangerous blood clots that can lodge in the legs or lungs, a major study suggests.... Merck ends study of cholesterol drugHeadlines from the Associated Press Wed, 05/21/2008 - 14:37
TRENTON, N.J. (AP) -- Merck & Co. has halted a study of an experimental drug it had touted as key to energizing its sagging cholesterol franchise, barely three weeks after U.S. regulators refused to allow sales of the drug.... Doctors Wary After Cholesterol Drug FlopHeadlines from the Associated Press Sun, 03/30/2008 - 11:26
CHICAGO (AP) -- Full results of a failed trial on Vytorin, a medicine taken by millions of Americans to lower cholesterol, left doctors stunned that the drug did not improve heart disease even though it worked as intended to lower three key risk factors.... |
